T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.462
-0.021 (-4.39%)
At close: Nov 20, 2024, 4:00 PM
0.470
+0.008 (1.78%)
Pre-market: Nov 21, 2024, 4:00 AM EST
T2 Biosystems Revenue
T2 Biosystems had revenue of $1.99M in the quarter ending September 30, 2024, with 34.85% growth. This brings the company's revenue in the last twelve months to $7.68M, down -30.19% year-over-year. In the year 2023, T2 Biosystems had annual revenue of $7.19M, down -67.75%.
Revenue (ttm)
$7.68M
Revenue Growth
-30.19%
P/S Ratio
0.63
Revenue / Employee
$67,938
Employees
113
Market Cap
9.50M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.19M | -15.11M | -67.75% |
Dec 31, 2022 | 22.31M | -5.75M | -20.50% |
Dec 31, 2021 | 28.06M | 9.93M | 54.76% |
Dec 31, 2020 | 18.13M | 9.80M | 117.52% |
Dec 31, 2019 | 8.34M | -2.16M | -20.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Star Equity Holdings | 47.15M |
Dominari Holdings | 12.59M |
QT Imaging Holdings | 4.04M |
PAVmed | 4.03M |
Alterity Therapeutics | 2.68M |
Lyra Therapeutics | 1.47M |
TTOO News
- 6 days ago - T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewsWire
- 5 weeks ago - T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript - Seeking Alpha
- 6 weeks ago - T2 Biosystems to Host Business Update Call on October 10, 2024 - GlobeNewsWire
- 6 weeks ago - T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - GlobeNewsWire
- 2 months ago - T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union - GlobeNewsWire
- 3 months ago - T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - T2 Biosystems to Attend Upcoming Investor Conferences - GlobeNewsWire